These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30688316)

  • 21. Development of a functional assessment scale for ambulatory boys with Duchenne muscular dystrophy.
    Scott E; Eagle M; Mayhew A; Freeman J; Main M; Sheehan J; Manzur A; Muntoni F;
    Physiother Res Int; 2012 Jun; 17(2):101-9. PubMed ID: 21954141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative muscle MRI: A powerful surrogate outcome measure in Duchenne muscular dystrophy.
    Bonati U; Hafner P; Schädelin S; Schmid M; Naduvilekoot Devasia A; Schroeder J; Zuesli S; Pohlman U; Neuhaus C; Klein A; Sinnreich M; Haas T; Gloor M; Bieri O; Fischmann A; Fischer D
    Neuromuscul Disord; 2015 Sep; 25(9):679-85. PubMed ID: 26096788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ambulatory Duchenne muscular dystrophy children: cross-sectional correlation between function, quantitative muscle ultrasound and MRI.
    Abdulhady H; Sakr HM; Elsayed NS; El-Sobky TA; Fahmy N; Saadawy AM; Elsedfy H
    Acta Myol; 2022 Mar; 41(1):1-14. PubMed ID: 35465338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Walking and weakness in children: a narrative review of gait and functional ambulation in paediatric neuromuscular disease.
    Kennedy RA; Carroll K; McGinley JL; Paterson KL
    J Foot Ankle Res; 2020 Mar; 13(1):10. PubMed ID: 32122377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reliability and validity analyses of the North Star Ambulatory Assessment in Brazilian Portuguese.
    Okama LO; Zampieri LM; Ramos CL; Toledo FO; Alves CRJ; Mattiello-Sverzut AC; Mayhew A; Sobreira CFR
    Neuromuscul Disord; 2017 Aug; 27(8):723-729. PubMed ID: 28648683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corticosteroids in Duchenne muscular dystrophy: impact on the motor function measure sensitivity to change and implications for clinical trials.
    Schreiber A; Brochard S; Rippert P; Fontaine-Carbonnel S; Payan C; Poirot I; Hamroun D; Vuillerot C;
    Dev Med Child Neurol; 2018 Feb; 60(2):185-191. PubMed ID: 28990163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rasch analysis of the 32-item motor function measure in ambulant patients with Duchenne muscular dystrophy.
    Huang M; Chen T; Zhou C; Wang Y; Zeng H; Lu X; Cao J
    Clin Rehabil; 2023 Apr; 37(4):569-582. PubMed ID: 36285505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ambulatory capacity in Japanese patients with Duchenne muscular dystrophy.
    Awano H; Itoh C; Takeshima Y; Lee T; Matsumoto M; Kida A; Kaise T; Suzuki T; Matsuo M
    Brain Dev; 2018 Jun; 40(6):465-472. PubMed ID: 29551259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative electromyography in ambulatory boys with Duchenne muscular dystrophy.
    Verma S; Lin J; Travers C; McCracken C; Shah D
    Muscle Nerve; 2017 Dec; 56(6):1168-1171. PubMed ID: 28457006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cumulative jerk as an outcome measure in nonambulatory Duchenne muscular dystrophy.
    Fujii T; Takeshita E; Iwata Y; Yajima H; Nozaki F; Mori M; Kumada T
    Brain Dev; 2019 Oct; 41(9):796-802. PubMed ID: 31213334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal Evaluation of Muscle Composition Using Magnetic Resonance in 4 Boys With Duchenne Muscular Dystrophy: Case Series.
    Senesac CR; Lott DJ; Forbes SC; Mathur S; Arpan I; Senesac ES; Walter GA; Vandenborne K
    Phys Ther; 2015 Jul; 95(7):978-88. PubMed ID: 25592189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Six-minute walk test versus two-minute walk test in children with Duchenne muscular dystrophy: Is more time more information?
    Vill K; Ille L; Schroeder SA; Blaschek A; Müller-Felber W
    Eur J Paediatr Neurol; 2015 Nov; 19(6):640-6. PubMed ID: 26455815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of motor and respiratory function in Duchenne muscular dystrophy patients.
    Luiz LC; Marson FAL; Bresciani Almeida CC; Toro AADC; Nucci A; Ribeiro JD
    Respir Physiol Neurobiol; 2019 Apr; 262():1-11. PubMed ID: 30660861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a multicomponent nutritional supplement on functional outcomes for Duchenne muscular dystrophy: A randomized controlled trial.
    Davidson ZE; Hughes I; Ryan MM; Kornberg AJ; Cairns AG; Jones K; Hutchence M; Sampaio H; Morrison M; Truby H
    Clin Nutr; 2021 Jul; 40(7):4702-4711. PubMed ID: 34237697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association Between Health-Related Quality of Life and Motor Function in Ambulant and Nonambulant Duchenne Muscular Dystrophy Patients.
    Gocheva V; Schmidt S; Orsini AL; Hafner P; Schaedelin S; Rueedi N; Weber P; Fischer D
    J Child Neurol; 2019 Dec; 34(14):873-885. PubMed ID: 31385745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative muscle MRI biomarkers in Duchenne muscular dystrophy: cross-sectional correlations with age and functional tests.
    Sherlock SP; Zhang Y; Binks M; Marraffino S
    Biomark Med; 2021 Jun; 15(10):761-773. PubMed ID: 34155911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantifying disease activity in fatty-infiltrated skeletal muscle by IDEAL-CPMG in Duchenne muscular dystrophy.
    Mankodi A; Bishop CA; Auh S; Newbould RD; Fischbeck KH; Janiczek RL
    Neuromuscul Disord; 2016 Oct; 26(10):650-658. PubMed ID: 27593185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Longitudinal Study of Quantitative Muscle Strength and Functional Motor Ability in Ambulatory Boys with Duchenne Muscular Dystrophy.
    Buckon CE; Sienko SE; Fowler EG; Bagley AM; Staudt LA; Sison-Williamson M; Heberer KR; McDonald CM; Sussman MD
    J Neuromuscul Dis; 2022; 9(2):321-334. PubMed ID: 34924398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection Approach to Identify the Optimal Biomarker Using Quantitative Muscle MRI and Functional Assessments in Becker Muscular Dystrophy.
    van de Velde NM; Hooijmans MT; Sardjoe Mishre ASD; Keene KR; Koeks Z; Veeger TTJ; Alleman I; van Zwet EW; Beenakker JM; Verschuuren JJGM; Kan HE; Niks EH
    Neurology; 2021 Aug; 97(5):e513-e522. PubMed ID: 34162720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study.
    McDonald CM; Henricson EK; Abresch RT; Florence JM; Eagle M; Gappmaier E; Glanzman AM; ; Spiegel R; Barth J; Elfring G; Reha A; Peltz S
    Muscle Nerve; 2013 Sep; 48(3):343-56. PubMed ID: 23681930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.